These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8038359)

  • 41. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
    Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical correlation on a subject with esophagitis].
    Blum AL
    Rev Med Suisse Romande; 1993 Aug; 113(8):662. PubMed ID: 8372315
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prognostic markers in reflux esophagitis better than wrapped up recommendations].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Dec; 89(49):4243-4. PubMed ID: 1461046
    [No Abstract]   [Full Text] [Related]  

  • 44. [Maintenance treatment in reflux esophagitis: the role of omeprazole].
    Díaz de Rojas F; Castelló M; Mariño M
    Rev Esp Enferm Dig; 1992 Mar; 81(3):215-8. PubMed ID: 1567727
    [No Abstract]   [Full Text] [Related]  

  • 45. Which patients with ulcer- or reflux-like dyspepsia will respond favorably to omeprazole?
    Singh A; Newton W
    J Fam Pract; 2001 Apr; 50(4):365. PubMed ID: 11300989
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Healing of chronic psoriasis vulgaris while using omeprazole].
    Hasselkus W
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):46. PubMed ID: 8420774
    [No Abstract]   [Full Text] [Related]  

  • 49. Omeprazole for peptic ulcer in Crohn's disease.
    Bianchi Poro G; Ardizzone S; Petrillo M; Desideri S
    Am J Gastroenterol; 1991 Feb; 86(2):245-6. PubMed ID: 1992643
    [No Abstract]   [Full Text] [Related]  

  • 50. [Omeprazole: a step forward in the therapy of acido-peptic disease].
    Piqué JM
    Med Clin (Barc); 1992 Jun; 99(5):179-82. PubMed ID: 1507897
    [No Abstract]   [Full Text] [Related]  

  • 51. Omeprazole.
    Lancet; 1987 Dec; 2(8573):1467. PubMed ID: 2892029
    [No Abstract]   [Full Text] [Related]  

  • 52. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
    Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
    Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of gastroduodenal ulcers and peptic esophagitis with a deproteinized calf serum extract].
    Debray C; Paolaggi JA; Couturier D
    Therapeutique; 1972 Mar; 48(3):199-206. PubMed ID: 5071021
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy of peptic ulcer. ATPase inhibitors].
    Arnold R
    Verh Dtsch Ges Inn Med; 1988; 94():276-81. PubMed ID: 2974671
    [No Abstract]   [Full Text] [Related]  

  • 55. [A meeting of experts in Washington. Omeprazole: important progress in the treatment of gastric pathology. Activity and cicatrization rate in ulcer are highlighted].
    Rev Clin Esp; 1989; 185(3):suppl 2p.. PubMed ID: 2623222
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of erosive-ulcerous disorders of the upper gastrointestinal tract with dibunol].
    Emanuél' NM; Andrianova OP; Sokolov LK; Korman DB; Krutova TV
    Sov Med; 1986; (6):96-9. PubMed ID: 3750058
    [No Abstract]   [Full Text] [Related]  

  • 57. Omeprazole therapy in resistant reflux disease.
    Waldum HL; Brenna E
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7888009
    [No Abstract]   [Full Text] [Related]  

  • 58. Omeprazole therapy in resistant reflux disease.
    Wright JM; Sarich TC
    Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7810947
    [No Abstract]   [Full Text] [Related]  

  • 59. Resolving problems in the use of omeprazole.
    Am J Hosp Pharm; 1991 Nov; 48(11):2380, 2382-3. PubMed ID: 1746565
    [No Abstract]   [Full Text] [Related]  

  • 60. Combined therapies for upper gastrointestinal disorders--any advantage?
    Guslandi M
    Lancet; 1988 Jun; 1(8599):1383-5. PubMed ID: 2898054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.